Abstract
The aim of the present study was to characterize neuroprotective activity of NS-7, a mixed voltage-gated sodium and calcium channel blocker in a model of transient focal ischemia in rats. Ischemia was induced by a 75-min reversible occlusion of middle cerebral artery (MCAo) using a nylon filament. NS-7 (0.5 mg/kg i.v.) or 0.9% NaCl (1 ml/kg i.v.) were infused over 3 min starting 30 min after the MCAo. Infarct analysis was performed 72 h after ischemia. Application of NS-7 produced significant protection seen in neurological tests and diminished brain damage by 37% in total infarct (17.7±3.0% vs. 27.9±3.2% control; p<0.01; t-test), by 47.8% in cortical infarct size (8.5±2.4% vs. 16.2±2.4% control; p<0.01) and by 21.5% in striatal infarction (9.2±0.8% vs. 11.7±0.9% control; p<0.05). The results indicate that NS-7 has potential for neuroprotection against transient ischemic insult.
Similar content being viewed by others
References
Aoki, Y., Shibahara, R., Itoh, Y., Yoshikuni, Y. and Kimura, K. (1997) “Cerebroprotective effects of NS-7, a novel pyrimidine derivative, in rats after permanent middle cerebral artery occlusion”, Jpn. J. Pharmacol. (Suppl.), 90.
Aronowski, J., Strong, R. and Grotta, J.C. (1996) “Combined neuroprotection and reperfusion therapy for stroke: Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia”, Stroke 27, 1571–1577.
Back, T., Ginsberg, M.D., Dietrich, W.D. and Watson, B.D. (1996) “Induction of spreading depression in the ischemic hemisphere following experimental middle cerebral artery occulusion: effect on infarct morphology”, J. Cereb. Blood Flow Metab. 16, 202–213.
Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L., and Bartkowski, H. (1986) “Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination”, Stroke 17, 472–476.
Benham, C.D., Brown, T.H., Cooper, D.G., Evans, M.L., Harries, M.H., Herdon, H.J., Meakin, J.E., Murkitt, K.L., Patel, S.R., Roberts, J.C., Rothaul, A.L., Smith, S.J., Wood, N. and Hunter, A.J. (1993) “SB-201823-a, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemia”, Neuropharmacology 32, 1249–1257.
Buchan, A.M., Gertler, S.Z., Li, H., Xue, D., Huang, Z.G., Chaundy, K.E., Barnes, K. and Lesiuk, H.J. (1994) “A selective n-type Ca2+-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia”, J. Cereb. Blood Flow Metab. 14, 903–910.
Clark, R.K., Lee, E.V., Fish, C.J., White, R.F., Price, W.J., Jonak, Z.L.. Feuerstein, G.Z. and Barone, F.C. (1993) “Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative planimetric study”, Brain Res. Bull. 31, 565–572.
De Ryck, M. (1997) “Protection of neurological function in stroke models and neuroprotective properties of lubeluzole”, Cerebrovasc. Dis. 7, 18–30.
Doble, A. (1996) “The pharmacology and mechanism of action of riluzole”, Neurology 47, S233-S241.
Du, C., Hu, R., Csernansky, C.A., Hsu, C.Y. and Choi, D.W. (1996) “Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis?”, J. Cereb. Blood Flow Metab. 16, 195–201.
Geter-Douglass, B. and Witkin, J.M. (1999) “Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice”, Psychopharmacology 146, 280–289.
Ginsberg, M.D., Belayev, L. and Zhao, W.Z. (1997) “Recruitment of the ischemic penumbra into the necrotic core”, Cerebrovasc. Dis. 7, 14–18.
Goldin, S.M., Subbarao, K., Sharma, R., Knapp, A.G., Fischer, J.B., Daly, D., Durant, G.J., Reddy, N.L., Hu, L.Y. and Magar, S. (1995) “Neuroprotective use-dependent blockers of Na+ and Ca2+ channels controlling presynaptic release of glutamate”, Ann. N.Y. Acad. Sci. 765, 210–229.
Hossmann, K.A. (1994) “Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised”, Brain Pathol. 4, 23–36.
Itoh, Y., Aoki, Y., Nonaka, K., Ukai, Y., Yoshikuni, Y. and Kimura, K. (1997) “Permeability of a neuroprotective compound NS-7 into brain: comparison between normal and middle cerebral artery-occluded rats”, Life Sci. 61, 957–966.
Kimelberg, H.K., Goderie, S.K., Higman, S., Pang, S. and Waniewski, R.A. (1990) “Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures”, J. Neurosci. 10, 1583–1591.
Lekieffre, D., Benavides, J., Scatton, B. and Nowicki, J.P. (1997) “Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model”, Brain Res. 776, 88–95.
Liu, Y., Belayev, L., Zhao, W., Busto, R. and Ginsberg, M.D. (2000) “MRZ 2/579, a novel uncompetitive N-methyl-d-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal ischemia in rats”, Brain Res. 862, 111–119.
Longa, E.Z., Weinstein, P.R., Carlson, S. and Cummins, R. (1989) “Reversible middle cerebral artery occlusion without craniectomy in rats”, Stroke 20, 84–91.
Lynch, J.J., Yu, S.P., Canzoniero, L.M.T., Sensi, S.L. and Choi, D.W. (1995) “Sodium channel blockers reduce oxygen-glucose deprivation-induced cortical neuronal injury when combined with glutamate receptor antagonists”, J. Pharmacol. Exp. Ther. 273, 554–560.
Mcculloch, J. (1992) “Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man”, Br. J. Clin. Pharmacol. 34, 106–114.
O’Neill, M.J., Bath, C.P., Dell, C.P., Hicks, C.A., Gilmore, J., Ambler, S.J., Ward, M.A. and Bleakman, D. (1997) “Effects of Ca(2+) and Na(+) channel inhibitors in vitro and in global cerebral ischaemia in vivo”, Eur. J. Pharmacol. 332, 121–131.
Obrenovitch, T.P. and Urenjak, J. (1998) “Glutamate release inhibitors: a critical assessment of their action mechanism”, Amino Acids 14, 143–150.
Oka, M., Itoh, Y., Ukai, Y. and Kimura, K. (1999) “Blockade by NS-7, a neuroprotective compound, of both L-type and P/Q-type Ca2+ channels involving depolarization-stimulated nitric oxide synthase activity in primary neuronal culture”, J. Neurochem. 72, 1315–1322.
Paschen, W. (1996) “Glutamate excitotoxicity in transient global cerebral ischemia”, Acta Neurobiol. Exp. 56, 313–322.
Pratt, J., Rataud, J., Bardot, F., Roux, M., Blanchard, J.C., Laduron, P.M. and Stutzmann, J.M. (1992) “Neuroportective actions of Riluzole in rodent models of global and focal cerebral ischaemia”, Neurosci. Lett. 140, 225–230.
Rami, A. and Krieglstein, J. (1994) “Neuronal protective effects of calcium antagonists in cerebral ischemia”, Life Sci. 55, 2105–2113.
Read, S.J., Hirano, T., Davis, S.M. and Donnan, G.A. (1999) “Limiting neurological damage after stroke—a review of pharmacological treatment options”, Drug Aging 14, 11–39.
Rogawski, M. (2000) “Low affinity channel blocking (uncompetitive) NMDA receptor antagonists as therapeutic agents— toward an understanding of their favourable tolerability”, Amino Acids 19, 133–149.
Shimidzu, T., Itoh, Y., Tatsumi, S., Hayashi, S., Ukai, Y., Yoshikuni, Y. and Kimura, K. (1997) “Blockade of voltage-sensitive sodium channels by NS-7, a novel neuroprotective compound, in the rat brain”, Naunyn-Schmied. Arch. Pharmacol. 355, 601–608.
Smith, S.E., Hodges, H., Sowinski, P., Man, C.M., Leach, M.J., Sinden, J.D., Gray, J.A. and Meldrium, B.S. (1997) “Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat”, Neuroscience 77, 1123–1135.
Steiner, T. and Hacke, W. (1998) “Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke”, Eur. Neurol. 40, 1–8.
Suma, C., Hayashi, S., Ukai, Y., Yoshikuni, Y. and Kimura, K. (1997). “Na+ and high-voltage-activated Ca2+ channel blocking actions of NS-7, a novel neuroprotective agent, in NG108-15 cells”, Eur. J. Pharmacol. 336, 283–290.
Swanson, R.A., Morton, M.T., Tsao-Wu, G., Savalos, R.A., Davidson, C. and Sharp, F.R. (1990) “A semiautomated method for measuring brain infarct volume”, J. Cereb. Blood Flow Metab. 10, 290–293.
Takagaki, Y., Itoh, Y., Aoki, Y., Ukai, Y., Yoshikuni, Y. and Kimura, K. (1997) “Inhibition of ischemia-induced fodrin breakdown by a novel phenylpyrimidine derivative NS-7: an implication for its neuroprotective action in rats with middle cerebral artery occlusion”, J. Neurochem. 68, 2507–2513.
Tatsumi, S., Itoh, Y., Ma, F.H., Higashira, H., Ukai, Y., Yoshikuni, Y. and Kimura, K. (1998a) “Inhibition of depolarization-induced nitric oxide synthase activation by NS-7, a phenylpyrimidine derivative, in primary neuronal culture”, J. Neurochem. 70 59–65.
Tatsumi, S., Itoh, Y., Ukai, Y. and Kimura, K. (1998b) “A novel Na+/Ca2+ channel blocker, NS-7, suppresses hypoxic injury in rat cerebrocortical slices”, Naunyn-Schmied. Arch. Pharmacol. 358, 191–196.
Turski, L. (1990) “N-methyl-d-aspartate receptor complex. Different sites for regulation and clinical consequences”, Arzneimittelforschung 40, 511–514.
Urenjak, J. and Obrenovitch, T.P. (1996) “Pharmacological modulation of voltage-gated Na+ channels: a rational and effective strategy against ischemic drain damage”, Pharmacol. Rev. 48, 21–67.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sopala, M., Danysz, W. & Quack, G. Neuroprotective effects of NS-7, voltage-gated Na+/Ca2+ channel blocker in a rodent model of transient focal ischemia. neurotox res 4, 655–661 (2002). https://doi.org/10.1080/1029842021000045462
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/1029842021000045462